The Dermatology Specialists, the largest dermatology group in New York City, is thrilled to announce the successful acquisition of Delaware Valley Dermatology.

CommonSpirit Health has officially launched a nationwide platform called the Population Health Services Organization (PHSO) aimed at enhancing access to equitable healthcare, elevating care quality and outcomes, and reducing healthcare costs

ChoiceSpine LLC, a privately held spinal device company based in Knoxville, TN and held by Altus Capital Partners, is excited to announce that it has received FDA clearance

Quanta Dialysis Technologies?, a dedicated medical technology company focused on improving kidney care accessibility, announced the submission of a 510(k) premarket notification to the U.S. Food and Drug Administration (FDA).

MiRus has officially introduced the ATLAS? MoRe? Foot and Ankle Plating System to the U.S. market, representing a groundbreaking advancement in the treatment of foot and ankle conditions.

B. Braun Medical Inc. (B. Braun), a prominent leader in the field of intelligent infusion therapy and pain management, has announced its receipt of 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the AQUAbase nX Reverse Osmosis System.

Vial, a global Contract Research Organization (CRO) specializing in cutting-edge clinical trial management services, has formed a strategic partnership with MLM Medical Labs

Redefine Healthcare is delighted to announce its collaboration with Mercer-Bucks Orthopedics, aimed at delivering the utmost standard of care to patients in the Tri-state area.

The American Urological Association (AUA) has unveiled the 2023 clinical practice guideline amendment for the diagnosis and treatment of early-stage testicular cancer.

Lightbeam Health Solutions, a leading provider of population health enablement technology and solutions, is thrilled to announce its relocation to a new, larger headquarters in Dallas, TX.